Treating agent for Paget's disease of bone
AssigneeTeijin Limited
InventorsSeiichi Ishizuka, Kazuya Takenouchi, Atsushi Imaizumi, Yasuhiro Oue, Noriyoshi Kurihara, Sakamuri V. Reddy, G. David Roodman
Life of this patent
Estimating the term…
Abstract
To obtain a treating agent for Paget's disease of bone, there is provided a method of inhibiting expression of general transcription factor of steroid hormone receptor.
Claims30
A method for treating Paget's disease of bone, comprising administering to a patient a compound which inhibits expression of general transcription factor with an interactive relation to steroid hormone receptor.
A method for inhibiting expression of general transcription factor, comprising administering a compound which inhibits expression of general transcription factor with an interactive relation to steroid hormone receptor.
A method for screening a compound for treatment of Paget's disease of bone, comprising the step of detecting expression of TAFII-17 gene, TAFII-135 gene or DRIP-205 gene.
Dependencies are inferred from the claim text.